86 related articles for article (PubMed ID: 19452318)
1. Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.
Jak M; Mous R; Remmerswaal EB; Spijker R; Jaspers A; Yagüe A; Eldering E; Van Lier RA; Van Oers MH
Leuk Lymphoma; 2009 May; 50(5):788-801. PubMed ID: 19452318
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.
Biancotto A; Dagur PK; Fuchs JC; Wiestner A; Bagwell CB; McCoy JP
Mod Pathol; 2012 Feb; 25(2):246-59. PubMed ID: 22101351
[TBL] [Abstract][Full Text] [Related]
4. T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.
Kiaii S; Kokhaei P; Mozaffari F; Rossmann E; Pak F; Moshfegh A; Palma M; Hansson L; Mashayekhi K; Hojjat-Farsangi M; Österborg A; Choudhury A; Mellstedt H
Cancer Immunol Immunother; 2013 Jan; 62(1):51-63. PubMed ID: 22736254
[TBL] [Abstract][Full Text] [Related]
5. Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome.
Rigo A; Vaisitti T; Laudanna C; Terrabuio E; Micillo M; Frusteri C; D'Ulivo B; Merigo F; Sbarbati A; Mellert K; Möeller P; Montresor A; Di Napoli A; Cirombella R; Butturini E; Massaia M; Constantin G; Vinante F; Deaglio S; Ferrarini I
Cell Death Dis; 2024 May; 15(5):323. PubMed ID: 38724507
[TBL] [Abstract][Full Text] [Related]
6. CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
Arroyo Hornero R; Georgiadis C; Hua P; Trzupek D; He LZ; Qasim W; Todd JA; Ferreira RC; Wood KJ; Issa F; Hester J
Commun Biol; 2020 Jul; 3(1):375. PubMed ID: 32665635
[TBL] [Abstract][Full Text] [Related]
7. Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
Woś J; Szymańska A; Lehman N; Chocholska S; Zarobkiewicz M; Pożarowski P; Bojarska-Junak A
Cells; 2023 Dec; 13(1):. PubMed ID: 38201234
[TBL] [Abstract][Full Text] [Related]
8. OMIP-095: 40-Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues.
Kare AJ; Nichols L; Zermeno R; Raie MN; Tumbale SK; Ferrara KW
Cytometry A; 2023 Nov; 103(11):839-850. PubMed ID: 37768325
[TBL] [Abstract][Full Text] [Related]
9. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; Calabrò M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
[TBL] [Abstract][Full Text] [Related]
10. Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression.
Mékinian A; Quinquenel A; Belkacem KA; Kanoun F; Dondi E; Franck E; Boubaya M; Mhibik M; Baran-Marszak F; Letestu R; Ajchenbaum-Cymbalista F; Lévy V; Varin-Blank N; Le Roy C
Cancer Gene Ther; 2023 Jul; 30(7):1018-1028. PubMed ID: 36973425
[TBL] [Abstract][Full Text] [Related]
11. CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.
Inaguma S; Ueki A; Lasota J; Komura M; Sheema AN; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Schrump DS; Hassan R; Miettinen M; Takahashi S
J Pathol Clin Res; 2023 May; 9(3):195-207. PubMed ID: 36754859
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential.
Yano M; Byrd JC; Muthusamy N
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497266
[TBL] [Abstract][Full Text] [Related]
13. FLOT and CROSS chemotherapy regimens alter the frequency of CD27
Davern M; Donlon NE; Sheppard AS; Majcher KD; Connell FO; Heeran AB; Grant M; Farrell RA; Hayes C; Bracken-Clarke D; Conroy MJ; Foley E; Toole DO; Bhardwaj A; Ravi N; Reynolds JV; Maher SG; Sullivan JO; Lysaght J
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3753-3774. PubMed ID: 35986757
[TBL] [Abstract][Full Text] [Related]
14. The contribution of human papilloma virus infection to cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
Bhavsar-Bhakta P; Hamza M; Mehravaran S; Krishnan B; He Q; Tyring S; Rady P; Rivero G; Cohen DN; Sosa IR
EJHaem; 2021 May; 2(2):228-235. PubMed ID: 35845291
[TBL] [Abstract][Full Text] [Related]
15. Somatic FOXC1 insertion mutation remodels the immune microenvironment and promotes the progression of childhood acute lymphoblastic leukemia.
Wang Y; Ma X; Huang J; Yang X; Kang M; Sun X; Li H; Wu Y; Zhang H; Zhu Y; Xue Y; Fang Y
Cell Death Dis; 2022 May; 13(5):431. PubMed ID: 35504885
[TBL] [Abstract][Full Text] [Related]
16. The CD70-CD27 axis in oncology: the new kids on the block.
Flieswasser T; Van den Eynde A; Van Audenaerde J; De Waele J; Lardon F; Riether C; de Haard H; Smits E; Pauwels P; Jacobs J
J Exp Clin Cancer Res; 2022 Jan; 41(1):12. PubMed ID: 34991665
[TBL] [Abstract][Full Text] [Related]
17. An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma.
De Meulenaere A; Vermassen T; Creytens D; De Keukeleire S; Delahaye T; Deron P; Duprez F; Fung S; Pauwels P; Ferdinande L; Rottey S
Clin Transl Sci; 2021 Nov; 14(6):2300-2313. PubMed ID: 34405542
[TBL] [Abstract][Full Text] [Related]
18. Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia.
Vitale C; Boccellato E; Comba L; Jones R; Perutelli F; Griggio V; Coscia M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359757
[TBL] [Abstract][Full Text] [Related]
19. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
Front Immunol; 2021; 12():662866. PubMed ID: 33841445
[TBL] [Abstract][Full Text] [Related]
20. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective.
Peters FS; Strefford JC; Eldering E; Kater AP
Haematologica; 2021 May; 106(5):1234-1243. PubMed ID: 33691381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
